4.2 Article

Immunodeficiency in a patient with microcephalic osteodysplastic primordial dwarfism type I as compared to Roifman syndrome

期刊

BRAIN & DEVELOPMENT
卷 43, 期 2, 页码 337-342

出版社

ELSEVIER
DOI: 10.1016/j.braindev.2020.09.007

关键词

Microcephalic osteodysplastic primordial dwarfism type I (MOPD I); Roifman syndrome; RNU4ATAC; Pachygyria; Corpus callosum dysgenesis; Immunodeficiency

资金

  1. AMED, Japan [JP18ek0109280, JP20ek0109486, JP20dm0107090, JP20ek0109301, JP20ek0109348, JP20kk0205012]
  2. JSPS KAKENHI, Japan [JP17H01539, JP19H03621]
  3. Takeda Science Foundation, Japan

向作者/读者索取更多资源

MOPD I, a rare genetic disorder, is characterized by severe intrauterine growth retardation, microcephaly, brain anomalies, and potential immunodeficiencies. The gene responsible for the disorder encodes small nuclear RNA rather than protein.
Background: Microcephalic osteodysplastic primordial dwarfism type I (MOPD I, also known as Taybi-Linder syndrome) is a rare genetic disorder associated with severe intrauterine growth retardation, short stature, microcephaly, brain anomalies, stunted limbs, and early mortality. RNU4ATAC, the gene responsible for this disorder, does not encode a protein but instead the U4atac small nuclear RNA (snRNA), a crucial component of the minor spliceosome. Roifman syndrome is an allelic disorder of MOPD I that is characterized by immunodeficiency complications. Case report: The patient described herein is an 18-year-old woman exhibiting congenital dwarfism and microcephaly with structural brain anomaly. She suffered human herpesvirus 6 (HHV-6)-associated acute necrotizing encephalopathy at the age of one, thereafter resulting in severe psychomotor disabilities. Genetic analysis using gene microarray and whole-exome sequencing could not identify the cause of her congenital anomalies. However, Sanger sequencing revealed a compound heterozygous mutation within RNU4ATAC (NR_023343.1:n.[50G > A];[55G > A]). Immunological findings showed decreases in total lymphocytes, CD4(+) T cells, and T cell regenerative activity. Furthermore, antibodies against varicella-zoster, rubella, measles, mumps, and influenza were very low or negative despite having received vaccinations for these viruses. HHV-6 IgG antibodies were also undetected. Discussion: The patient here exhibited a marked MOPD I phenotype complicated by various immunodeficiencies. Previous studies have not demonstrated immunodeficiency comorbidities within MOPD I subjects, but this report suggests an evident immunodeficiency in MOPD I. Patients with MOPD I should be treated with one of the immunodeficiency syndromes. (C) 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据